Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui Lv

Showing results (171-180 of 202) with videos related to

Pageof 21
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 28, 2025
Machine Learning-Based Radiomics in Malignancy Prediction of Pancreatic Cystic Lesions: Evidence from Cyst Fluid Multi-OmicsSihang Cheng, Ge Hu, Shenbo Zhang, et al.
Theranostics|April 14, 2025
Microglial Lcn2 knockout enhances chronic intracerebral hemorrhage recovery by restoring myelin and reducing inflammationLi Wang, Lei Zhang, Kai Wang, et al.
Expert Reviews in Molecular Medicine|June 19, 2023
Wnt/<i>β</i>-catenin signalling pathway in breast cancer cells and its effect on reversing tumour drug resistance by alkaloids extracted from traditional Chinese medicineXin-Lei Wu, Shen-Guo Lin, Yi-Wen Mao, et al.
Haematologica|May 29, 2025
Improving predictive accuracy in multiple myeloma using a plasma cell profile derived from single-cell RNA sequencingLanting Liu, Hao Sun, Fangshuo Feng, et al.
Cancer Medicine|February 13, 2024
Gemcitabine-based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: No difference in outcomesHuimin Liu, Hesong Zou, Dandan Shan, et al.
Haematologica|August 3, 2023
Minor clone of del(17p) provides a reservoir for relapse in multiple myelomaJian Cui, Rui Lv, Tengteng Yu, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Longitudinal genetically detectable minimal residual disease by fluorescence <i>in situ</i> hybridization confers a poor prognosis in myelomaJian Cui, Tengteng Yu, Rui Lv, et al.
Biomechanics and Modeling in Mechanobiology|November 11, 2024
Comparison and identification of human coronary plaques with/without erosion using patient-specific optical coherence tomography-based fluid-structure interaction models: a pilot studyYanwen Zhu, Chen Zhao, Zheyang Wu, et al.
Leukemia|April 12, 2024
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myelomaJian Cui, Yuntong Liu, Rui Lv, et al.
Chinese Medical Journal|September 17, 2025
Long-term outcomes of CNCT19 chimeric antigen receptor T-cell therapy in relapsed or refractory aggressive B-cell lymphomaWei Liu, Ting Xie, Zhuoxin Zhang, et al.
Pageof 21

Showing results (171-180 of 202) with videos related to

Sort By:
Pageof 21
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 28, 2025
Machine Learning-Based Radiomics in Malignancy Prediction of Pancreatic Cystic Lesions: Evidence from Cyst Fluid Multi-OmicsSihang Cheng, Ge Hu, Shenbo Zhang, et al.
Theranostics|April 14, 2025
Microglial Lcn2 knockout enhances chronic intracerebral hemorrhage recovery by restoring myelin and reducing inflammationLi Wang, Lei Zhang, Kai Wang, et al.
Expert Reviews in Molecular Medicine|June 19, 2023
Wnt/<i>β</i>-catenin signalling pathway in breast cancer cells and its effect on reversing tumour drug resistance by alkaloids extracted from traditional Chinese medicineXin-Lei Wu, Shen-Guo Lin, Yi-Wen Mao, et al.
Haematologica|May 29, 2025
Improving predictive accuracy in multiple myeloma using a plasma cell profile derived from single-cell RNA sequencingLanting Liu, Hao Sun, Fangshuo Feng, et al.
Cancer Medicine|February 13, 2024
Gemcitabine-based conditioning compared to BEAM/BEAC conditioning prior to autologous stem cell transplantation for non-Hodgkin lymphoma: No difference in outcomesHuimin Liu, Hesong Zou, Dandan Shan, et al.
Haematologica|August 3, 2023
Minor clone of del(17p) provides a reservoir for relapse in multiple myelomaJian Cui, Rui Lv, Tengteng Yu, et al.
Therapeutic Advances in Medical Oncology|January 22, 2024
Longitudinal genetically detectable minimal residual disease by fluorescence <i>in situ</i> hybridization confers a poor prognosis in myelomaJian Cui, Tengteng Yu, Rui Lv, et al.
Biomechanics and Modeling in Mechanobiology|November 11, 2024
Comparison and identification of human coronary plaques with/without erosion using patient-specific optical coherence tomography-based fluid-structure interaction models: a pilot studyYanwen Zhu, Chen Zhao, Zheyang Wu, et al.
Leukemia|April 12, 2024
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myelomaJian Cui, Yuntong Liu, Rui Lv, et al.
Chinese Medical Journal|September 17, 2025
Long-term outcomes of CNCT19 chimeric antigen receptor T-cell therapy in relapsed or refractory aggressive B-cell lymphomaWei Liu, Ting Xie, Zhuoxin Zhang, et al.
Pageof 21